Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy. [electronic resource]
Producer: 20180116Description: 308-309 p. digitalISSN:- 1879-0852
- Antibodies, Monoclonal, Humanized -- adverse effects
- Aspergillosis, Allergic Bronchopulmonary -- chemically induced
- Carcinoma, Renal Cell -- drug therapy
- Humans
- Immunocompromised Host
- Immunosuppressive Agents -- adverse effects
- Indoles -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Pyrroles -- therapeutic use
- Sunitinib
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.